Brought to you by
ECR 2019 / C-0037
Differential diagnosis of soft tissue tumours by using semi-quantitative and quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging
Congress: ECR 2019
Poster No.: C-0037
Type: Scientific Exhibit
Keywords: Musculoskeletal bone, Musculoskeletal joint, Musculoskeletal soft tissue, CT, MR, MR-Diffusion/Perfusion, Audit and standards, Complications, Contrast agent-intravenous, Cancer
Authors: Y. Zhang, D. Hao, W. Xu; Qingdao/CN
DOI:10.26044/ecr2019/C-0037

References

 

1.    Marzi S, Stefanetti L, Sperati F, et al (2016) Relationship between diffusion parameters derived from intravoxel incoherent motion MRI and perfusion measured by dynamic contrast-enhanced MRI of soft tissue tumors. NMR Biomed 29:6.

 

2.    Noebauer-Huhmann IM, Amann G, Krssak M, et al (2015) Use of diagnostic dynamic contrast-enhanced (DCE)-MRI for targeting of soft tissue tumour biopsies at 3T: preliminary results. Eur Radiol 25:2041-2048.

 

3.    Nakamura T, Matsumine A, Matsubara T, et al (2011) The symptom-to-diagnosis delay in soft tissue sarcoma influence the overall survival and the development of distant metastasis. J Surg Oncol 104:771-775.

 

4.    Khalifa F, Soliman A, El-Baz A, et al (2014) Models and methods for analyzing DCE-MRI: A review. Med Phys 41:1-32.

 

5.    Park MY, Jee WH, Sun KK, et al (2013) Preliminary Experience Using Dynamic MRI at 3.0 Tesla for Evaluation of Soft Tissue Tumors. Korean J Radiol 14:102-109.

 

6.    Verstraete KL, Lang P (2000) Bone and soft tissue tumors: the role of contrast agents for MR imaging. Eur J Radiol 34:229-246.

 

7.    Tuncbilek N, Karakas HM, Okten OO (2005) Dynamic contrast enhanced MRI in the differential diagnosis of soft tissue tumors. Eur J Radiol 53:500-505.

 

8.    Yang Q, Li LH, Zhang J, et al (2015) A new quantitative image analysis method for improving breast cancer diagnosis using DCE-MRI examinations. Med Phys 42:103-109.

 

9.    Li L, Wang K, Sun XL, et al (2015) Parameters of Dynamic Contrast-Enhanced MRI as Imaging Markers for Angiogenesis and Proliferation in Human Breast Cancer. Med Sci Monitor 21:376-382.

 

10.  Bergamino M, Bonzano L, Levrero F, et al (2014) A review of technical aspects of T1-weighted dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in human brain tumors. Phys Med 30:635-643.

 

11.  Zhang N, Zhang L, Qiu B, et al (2012) Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas. J Magn Reson Imaging 36:355-363.

 

12.  Alonzi R, Padhani AR, Allen C (2007) Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 63:335-350.

 

13.  Lowry M, Zelhof B, Liney GP, et al (2009) Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue. Invest Radiol 44:577-584.

 

14.  Kim JI, Lee IS, Song YS, et al (2016) Short-term follow-up MRI after unplanned resection of malignant soft-tissue tumours quantitative measurements on dynamic contrast enhanced and diffusion-weighted MR images. Br J Radiol 89:20160302.

 

15.  Nystrom LM, Reimer NB, Dean CW, et al (2015) Evaluation of imaging utilization prior to referral of musculoskeletal tumors: a prospective study. J Bone Joint Surg Am 97:10-15.

 

16.  Hansford BG, Stacy GS (2015) From tumor to trauma: etiologically deconstructing a unique differential diagnosis of musculoskeletal entities with high signal intensity on T1-weighted MRI. AJR 204:817-826.

 

17.  Sourbron SP, Buckley DL (2013) Classic models for dynamic contrast-enhanced MRI. NMR Biomed 26:1004-1027.

 

18.  Schacht DV, Drukker K, Pak I, et al (2015) Using quantitative image analysis to classify axillary lymph nodes on breast MRI: A new application for the Z 0011 Era. Eur J Radiol 84:392-397.

 

19.  Harry VN, Semple SI, Parkin DE, et al (2010) Use of new imaging techniques to predict tumour response to therapy. Lancet Oncol 11:92-102.

 

20.  O'Connor JPB, Jackson A, Parker GJM, et al (2012) Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies. Nat Rev Clin Oncol 9:167-177.

 

21.  Hylton N (2006) Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 24:3293.

 

22.  Miller JC, Pien HH, Sahani D, et al (2005) Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst 97:172-187.

 

23.  Turkbey B, Thomasson D, Pang Y, et al (2010) The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment. Diagn Interv Radiol 16:186-192.

 

24.  Geirnaerdt MJA, Hogendoorn PCW, Bloem JL, et al (2000) Cartilaginous Tumors: Fast Contrast-enhanced MR Imaging. Radiology 214:539-546.

 

25.  O'Connor JP, Jackson A, Parker GJ, et al (2007) DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 96:189-195.

 

26.  Agner SC, Rosen MA, Englander S, et al (2014) Computerized Image Analysis for Identifying Triple-Negative Breast Cancers and Differentiating Them from Other Molecular Subtypes of Breast Cancer on Dynamic Contrast-enhanced MR Images: A Feasibility Study. Radiology 272:91-99.

 

27.  Sourbron S (2010) Technical aspects of MR perfusion. Eur J Radiol 76:304-313.

 

28. Yankeelov TE, Gore JC (2007) Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples. Curr Med Imaging Rev 3:91-107.

 

29.  Paldino MJ, Barboriak DP (2009) Fundamentals of quantitative dynamic contrast-enhanced MR imaging. Magn Reson Imaging Clin N Am 17:277-289.

 

30.  Rodjan F, De Graaf P, Van der Valk P, et al (2012) Retinoblastoma: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. Am J Neuroradiol 33:2129-2135.

POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
SHARE THIS POSTER
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more